Peer-reviewed veterinary case report
Mitratapide treatment cuts fat and weight in obese Beagles
By Dobenecker, Britta et al.·Published in Veterinary research communications·2009·Department of Veterinary Sciences, Germany·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Effect of mitratapide on body composition, body measurements and glucose tolerance in obese Beagles.
- Species:
- dog
Plain-English summary
A group of obese Beagles was treated with a medication called mitratapide to help them lose weight and improve their health. After the treatment, the dogs lost an average of 14.2% of their body weight and a significant amount of fat, with their body fat percentage returning to normal levels. The treatment also appeared to help improve their glucose tolerance, which is important for managing blood sugar levels. Overall, the Beagles showed impressive results in fat loss and weight management after using mitratapide.
People also search for: Beagle weight loss medication · mitratapide for dogs · how to help my dog lose weight
Abstract
The objective of this study was to confirm that weight loss after treatment with mitratapide (Yarvitan®) is loss of adipose tissue. Obese dogs were treated with the recommended treatment schedule of mitratapide. Dual-energy X-ray absorptiometry (DEXA) was done before and after the treatment schedule. Body weight, feed consumption and pelvic circumference were recorded and a glucose tolerance test was performed. Dualenergy X-ray absorptiometry measurements showed an impressive loss of fat tissue, corresponding to a mean loss of approximately 41.6% of the body fat mass recorded before treatment. After treatment with mitratapide, the mean body fat percentage had returned within the normal range. At the end of the study, the dogs had lost on average 14.2% of their body weight and 15.2% of their pelvic circumference compared to baseline. The results also suggest that losing weight with mitratapide might help to reverse insulin resistance.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/19544001/